$233.85
$0.00 (0.00%)
End-of-day quote: 04/26/2024
NasdaqGS:UTHR
United Therapeutics Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $146.14 | $174.55 | 0.00% | 3 | $356.43B |
| PFE | Pfizer | NYSE | Outperform | $25.40 | $32.87 | 0.00% | 6 | $147.23B |
| AMGN | Amgen | NasdaqGS | Outperform | $269.98 | $303.65 | 0.00% | 8 | $144.81B |
| VRTX | Vertex Pharmaceuticals Inc | NASDAQ | Outperform | $397.48 | $457.59 | 0.00% | 11 | $101.91B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $883.20 | $961.26 | 0.00% | 8 | $96.37B |
| GSK | GSK | LSE | Outperform | £16.53 | £17.30 | 0.00% | 12 | £67.54B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $65.42 | $87.82 | 0.00% | 14 | $81.58B |
| BIIB | Biogen | NasdaqGS | Outperform | $208.90 | $299.62 | 0.00% | 13 | $29.36B |
| BAYN | Bayer | XTRA | Hold | 27.40€ | 45.15€ | 0.00% | 4 | 25.86€B |
| CE | Celanese | NYSE | Hold | $154.49 | $148.23 | 0.00% | 18 | $17.23B |
| VTRS | Viatris Inc | NASDAQ | Hold | $11.57 | $11.73 | 0.00% | 5 | $13.36B |
| LQDA | Liquidia | NasdaqCM | Outperform | $12.53 | $19.71 | 0.00% | 2 | $1.12B |
